Indian Scientists Develop Smart Cancer Drug RK-251

NEW DELHI, India — Indian scientists have developed a new experimental cancer drug designed to activate mainly inside tumour cells while remaining relatively inactive in healthy tissue, offering a potential targeted approach to cancer treatment. The drug, named RK-251, was developed through collaborative research involving the Institute of Advanced Study in Science and Technology and the Indian Institute of Technology-Guwahati.

Moderna Melanoma Vaccine Succeeds in Phase 3 Trial

CHICAGO, United States — Moderna’s personalized mRNA cancer therapy Intismeran has delivered positive results in a late-stage melanoma trial conducted with Merck, sending Moderna shares sharply higher on Wednesday. The treatment, when combined with Merck’s Keytruda, met its main goal of reducing cancer recurrence and also achieved a key secondary goal involving the prevention of cancer spread.

Ebola Outbreak Hits Women and Children Hard in Eastern DR Congo

ITURI, Democratic Republic of the Congo — Women and children are bearing a disproportionate share of the impact of an Ebola outbreak in eastern Democratic Republic of the Congo, with nearly one million people displaced in Ituri province and essential health services sharply disrupted, according to United Nations agencies.

PM Modi Pays Tribute to Munshi Premchand on Birth Anniversary, Says His Timeless Works Will Inspire Generations

Prime Minister Narendra Modi on Friday paid heartfelt tribute to legendary Hindi-Urdu writer Munshi Premchand on his birth anniversary, remembering him as one of India’s greatest literary figures whose writings continue to influence readers across generations. The Prime Minister said Premchand’s timeless works, deeply rooted in realism, social equality and human values, remain as relevant today as they were when they were first written.